In a recent development surrounding the anticipated return of PML-N supremo Nawaz Sharif to Pakistan after four years in self-imposed exile, a crucial medical report has been submitted to the Lahore High Court (LHC) shedding light on his health condition. The report reveals that the former premier continues to experience “some residual anginal symptoms,” necessitating ongoing medical monitoring in both London and Pakistan. Angina, characterized by chest pain or discomfort, is a common symptom of coronary heart disease.
Nawaz Sharif had departed for London in 2019 during his seven-year jail term, citing medical reasons. Initially granted permission by the LHC to travel abroad for four weeks, extendable based on medical assessments, his brother, Shehbaz Sharif, had provided an undertaking to regularly furnish notarized medical reports from his doctors at the embassy to the court registrar.
However, Nawaz Sharif did not return as scheduled and was subsequently declared a proclaimed offender in multiple corruption cases. Now, with his planned return to Pakistan on October 21, as announced by Shehbaz Sharif, questions regarding his health and legal proceedings loom large.
The fresh medical report, submitted by Lawyer Amjad Pervez to the LHC registrar, underscores the complexity of Nawaz Sharif’s medical condition. The report, signed by Professor Carlo Di Mario, a consultant cardiologist at the Royal Brompton & Harefield Hospitals, part of Guy’s and St Thomas’ National Health Service Foundation Trust, highlights the extensive medical history and interventions Nawaz Sharif has undergone during his stay in London.
According to Professor Carlo Di Mario, they initially attempted medical treatment, intensifying his antianginal therapy. However, due to persistent anginal symptoms and the challenges posed by the COVID-19 pandemic, a safe return to Pakistan was not recommended. In November 2022, another angioplasty was performed, targeting an occluded left circumflexed artery. This complex procedure involved rotational atherectomy, intravascular lithotripsy, and the deployment of multiple stents under IVUS (Intravascular ultrasound) guidance.
Despite these interventions, Nawaz Sharif still experiences residual anginal symptoms. His condition is complicated by diffuse distal coronary disease, diabetes, and multiple other comorbidities, necessitating frequent follow-up investigations both in London and Pakistan.
This medical report adds a layer of complexity to Nawaz Sharif’s planned return to Pakistan. His health condition and the need for ongoing medical care raise questions about his ability to actively participate in legal proceedings. As the nation awaits his return, the intersection of health concerns and legal matters will undoubtedly be a topic of significant discussion and consideration.